Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry.
Kanenawa K, Yamaji K, Morimoto T, Yamamoto K, Domei T, Hyodo M, Shiomi H, Furukawa Y, Nakagawa Y, Kadota K, Watanabe H, Yoshikawa Y, Tada T, Tazaki J, Ehara N, Taniguchi R, Tamura T, Iwakura A, Tada T, Suwa S, Toyofuku M, Inada T, Kaneda K, Ogawa T, Takeda T, Sakai H, Yamamoto T, Tambara K, Esaki J, Eizawa H, Yamada M, Shinoda E, Nishizawa J, Mabuchi H, Tamura N, Shirotani M, Nakayama S, Uegaito T, Matsuda M, Takahashi M, Inoko M, Kanemitsu N, Tamura T, Ishii K, Nawada R, Onodera T, Ohno N, Koyama T, Tsuneyoshi H, Sakamoto H, Aoyama T, Miki S, Tanaka M, Sato Y, Yamazaki F, Hanyu M, Soga Y, Komiya T, Minatoya K, Ando K, Kimura T. Kanenawa K, et al. Among authors: sakamoto h. J Cardiol. 2024 Oct;84(4):300-310. doi: 10.1016/j.jjcc.2024.05.011. Epub 2024 Jun 11. J Cardiol. 2024. PMID: 38871119
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.
Yamaji K, Shiomi H, Morimoto T, Matsumura-Nakano Y, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Kato ET, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Domei T, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Investigators. Yamaji K, et al. Among authors: sakamoto h. JACC Asia. 2022 Apr 12;2(3):294-308. doi: 10.1016/j.jacasi.2021.12.012. eCollection 2022 Jun. JACC Asia. 2022. PMID: 36411876 Free PMC article.
Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention.
Takeji Y, Morimoto T, Shiomi H, Kato ET, Imada K, Yoshikawa Y, Matsumura-Nakano Y, Yamamoto K, Yamaji K, Toyota T, Tada T, Tazaki J, Yamamoto E, Nakatsuma K, Suwa S, Ehara N, Taniguchi R, Tamura T, Watanabe H, Toyofuku M, Yamamoto T, Shinoda E, Mabuchi H, Inoko M, Onodera T, Sakamoto H, Inada T, Ando K, Furukawa Y, Sato Y, Kadota K, Nakagawa Y, Kimura T. Takeji Y, et al. Among authors: sakamoto h. Circ J. 2023 Jan 25;87(2):277-286. doi: 10.1253/circj.CJ-22-0517. Epub 2022 Nov 8. Circ J. 2023. PMID: 36351607 Free article.
Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial.
Shiomi H, Kozuma K, Morimoto T, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Uematsu M, Tarutani Y, Fujii K, Simonton CA, Kimura T; RESET Investigators. Shiomi H, et al. Circ Cardiovasc Interv. 2014 Jun;7(3):343-54. doi: 10.1161/CIRCINTERVENTIONS.113.001322. Epub 2014 May 6. Circ Cardiovasc Interv. 2014. PMID: 24803436 Clinical Trial.
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).
Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Takatsu Y, Nishikawa H, Yamamoto Y, Nakagawa Y, Hayashi Y, Iwabuchi M, Umeda H, Kawai K, Okada H, Kimura K, Simonton CA, Kozuma K; RESET Investigators. Kimura T, et al. Circulation. 2012 Sep 4;126(10):1225-36. doi: 10.1161/CIRCULATIONAHA.112.104059. Epub 2012 Jul 23. Circulation. 2012. PMID: 22824435 Clinical Trial.
Spontaneous remission from primary hypothyroidism.
Yamamoto T, Sakamoto H. Yamamoto T, et al. Among authors: sakamoto h. Ann Intern Med. 1978 Jun;88(6):808-9. doi: 10.7326/0003-4819-88-6-808. Ann Intern Med. 1978. PMID: 666141 No abstract available.
3,081 results